About Saranas
Saranas is a company based in Houston (United States) founded in 2011. Saranas has raised $29.46 million across 9 funding rounds from investors including Baird Capital, S3 Ventures and Houston Technology Center. Saranas operates in a competitive market with competitors including TISSIUM, Laminate Medical, Vivasure Medical, Cardival Medical and Aziyo Biologics, among others.
- Headquarter Houston, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$29.46 M (USD)
in 9 rounds
-
Latest Funding Round
$15.48 M (USD), Series B
Jul 19, 2021
-
Investors
Baird Capital
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Saranas
Unlock access to complete
Unlock access to complete
Funding Insights of Saranas
Saranas has successfully raised a total of $29.46M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $15.48 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Saranas
Saranas has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Baird Capital, S3 Ventures and Houston Technology Center.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity and venture capital investments in B2B Tech & Services companies.
|
Locked | Locked | Locked | |
|
Venture capital investments are provided to Texas-based startups.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Saranas
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Saranas
Investment portfolio details for Saranas
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Saranas
Detailed financials for Saranas
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Saranas Comparisons
Peer comparison for Saranas
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Saranas
Saranas operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TISSIUM, Laminate Medical, Vivasure Medical, Cardival Medical and Aziyo Biologics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vascular sealants for open surgery are developed by TISSIUM.
|
|
| Locked | Locked | Locked |
AV fistula maturation and patency are supported by VasQ device.
|
|
| Locked | Locked | Locked |
Bioabsorbable implants and delivery systems for arteriotomy closure are developed.
|
|
| Locked | Locked | Locked |
A device for vascular access management is developed.
|
|
| Locked | Locked | Locked |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
Detailed competitors of Saranas
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Saranas
Complete news archive for Saranas
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saranas
Saranas was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Saranas is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Saranas is a funded company, having raised a total of $29.46M across 9 funding rounds to date.
Saranas was founded in 2011 and is headquartered in Houston, United States. Operations focus on the medical device sector, where a tool called Early Bird is created to identify internal bleeding risks in catheterization procedures. The device incorporates a cardiac sheath integrated with electrodes that assess electrical resistance variations across blood vessels, supporting safer vascular interventions.
Saranas's top competitors include TISSIUM, Vivasure Medical and Cardival Medical.
Saranas has 3 investors. Key investors include Baird Capital, S3 Ventures, and Houston Technology Center.